title: Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma.
abstract: The aim of the present study was to develop theophylline fast release enteric-coated pellets as a pulsatile drug delivery to the colon. The novelty of this work is the combination of pH and time-dependant enteric polymers as a single coating for the development of multiparticulate formulation. Theophylline pellets were optimized by applying a 2-factors 3-levels full factorial design. Continuous dissolution studies were carried out in simulated gastric, intestinal, and colonic fluid with pH 1.2 (0.1 N HCl), pH 7.4 and pH 6.8 (phosphate buffer), respectively. The lag time prior to the drug release was highly affected by combination of two factors, i.e. the percentage of Eudragit RL100 in polymer mixture and coating level. The formulation containing Eudragit RL100 and Eudragit S100 with a ratio of 4:1 and coating level of 12%w/w was found to be optimum. The results of serum study in New Zealand rabbits showed that the developed formulation provided a significant lag phase of 5 h. The present study demonstrates that the theophylline enteric-coated pellets could be successfully colon targeted by the design of pH- and time-dependant modified chronopharmaceutical formulation. In conclusion, pulsatile drug release over a period of 3-12 h is consistent with the requirements for chronopharmaceutical drug delivery.
authors.affiliation: Department of Pharmaceutics and Quality assurance, R. C. Patel Institute of Pharmaceutical Education and Research, Near Karwand Naka, Shirpur, Dist. Dhule, Maharashtra, India.
authors.forename: Vinayak D
authors.initials: VD
authors.lastname: Kadam
authors.forename: Surendra G
authors.initials: SG
authors.lastname: Gattani
mesh_terms: D000180:Acrylic Resins / Q000737:chemistry; D000818:Animals; D001249:Asthma / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003106:Colon / Q000378:metabolism*; D003692:Delayed-Action Preparations; D055870:Drug Chronotherapy; D016503:Drug Delivery Systems; D005079:Excipients / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D008297:Male; D011109:Polymethacrylic Acids / Q000737:chemistry; D011817:Rabbits; D012995:Solubility; D013806:Theophylline / Q000008:administration & dosage* / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000180:Acrylic Resins; D001993:Bronchodilator Agents; D003692:Delayed-Action Preparations; D005079:Excipients; D011109:Polymethacrylic Acids; C038300:methylmethacrylate-methacrylic acid copolymer; C050528:Eudragit RS; D013806:Theophylline